leftspacer middlespacer rightspacer
Media Menu
Featured Material


MAPS BULLETIN
MAPS Bulletin Summer 2014: Research Edition
 
Media > Recent and Archival
July 4, 2014

High Hopes | Can Ecstasy Treat The Agony of PTSD?

By: Kai Kupferschmidt

Science

Science catalogues the reemergence of international research into the therapeutic use of psychedelics. The article details work conducted by MAPS to develop psychedelic-assisted psychotherapy into prescription treatment options for a variety of medical conditions, highlighting clinical research into LSD-assisted psychotherapy for anxiety associated with advanced-stage illness, ibogaine-assisted therapy for opiate addiction, and MDMA-assisted psychotherapy for PTSD. “I believe in people’s basic human right to use molecules to explore their consciousness,” MAPS Founder Rick Doblin, Ph.D., tells Science.


Originally appearing here.

Download the PDF version of this article.


Back to MAPS in the Media

Give Our Veterans Hope
1 in 7 Iraq and Afghanistan veterans suffer from PTSD, in many cases leading to suicide. We owe it to our veterans to stop this epidemic.

Tell the Pentagon to fund MAPS' groundbreaking work to treat PTSD.